Still in a food or shopping coma from this week? Here’s some easy reading to catch you up on what you missed in healthcare innovation news.
The U.S. Preventive Services Task Force, which recommended against regular PSA testing and annual breast cancer screening before age 50 for U.S. men and women, respectively, this week recommended for regular HIV testing in nearly everyone over age 15.
A new healthcare angel fund focused on out-of-the-box ideas for cutting costs and improving efficiency in acute care emerged.
San Diego company Organovo showed us that developing tissue not just for drug discovery but for therapies is not too far fetched.
Papa Johns and other chain restaurants continue to sound off about having to provide health insurance to employees under the Affordable Care Act.
Medtronic isn’t joining others in the fight to repeal the medical device tax because, in the words of its CEO, it likes to “focus on things we can control.”
EHR company Imagine MD shut its doors, serving as a reminder of the inevitable consolidation to come.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Three weeks later, four New York hospitals are still closed due to damage from Sandy.
